305 related articles for article (PubMed ID: 11190023)
1. Frequency doubling perimetry and the detection of eye disease in the community.
Cioffi GA; Mansberger S; Spry P; Johnson C; Van Buskirk EM
Trans Am Ophthalmol Soc; 2000; 98():195-9; discussion 199-202. PubMed ID: 11190023
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of frequency-doubling technology for perimetrically normal eyes of open-angle glaucoma patients with unilateral field loss.
Fan X; Wu LL; Ma ZZ; Xiao GG; Liu F
Ophthalmology; 2010 Aug; 117(8):1530-7, 1537.e1-2. PubMed ID: 20466428
[TBL] [Abstract][Full Text] [Related]
3. Frequency doubling technology perimetry in open-angle glaucoma eyes with hemifield visual field damage: comparison of high-tension and normal-tension groups.
Murata H; Tomidokoro A; Matsuo H; Tomita G; Araie M
J Glaucoma; 2007 Jan; 16(1):9-13. PubMed ID: 17224743
[TBL] [Abstract][Full Text] [Related]
4. Relationship of SITA and full-threshold standard perimetry to frequency-doubling technology perimetry in glaucoma.
Boden C; Pascual J; Medeiros FA; Aihara M; Weinreb RN; Sample PA
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2433-9. PubMed ID: 15980232
[TBL] [Abstract][Full Text] [Related]
5. Can frequency-doubling technology and short-wavelength automated perimetries detect visual field defects before standard automated perimetry in patients with preperimetric glaucoma?
Ferreras A; Polo V; Larrosa JM; Pablo LE; Pajarin AB; Pueyo V; Honrubia FM
J Glaucoma; 2007; 16(4):372-83. PubMed ID: 17571000
[TBL] [Abstract][Full Text] [Related]
6. Relationship between Humphrey 30-2 SITA Standard Test, Matrix 30-2 threshold test, and Heidelberg retina tomograph in ocular hypertensive and glaucoma patients.
Bozkurt B; Yilmaz PT; Irkec M
J Glaucoma; 2008; 17(3):203-10. PubMed ID: 18414106
[TBL] [Abstract][Full Text] [Related]
7. Performance of frequency-doubling technology perimetry in a population-based prevalence survey of glaucoma: the Tajimi study.
Iwase A; Tomidokoro A; Araie M; Shirato S; Shimizu H; Kitazawa Y;
Ophthalmology; 2007 Jan; 114(1):27-32. PubMed ID: 17070580
[TBL] [Abstract][Full Text] [Related]
8. Detectability of glaucomatous changes using SAP, FDT, flicker perimetry, and OCT.
Nomoto H; Matsumoto C; Takada S; Hashimoto S; Arimura E; Okuyama S; Shimomura Y
J Glaucoma; 2009 Feb; 18(2):165-71. PubMed ID: 19225357
[TBL] [Abstract][Full Text] [Related]
9. Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss.
Medeiros FA; Sample PA; Weinreb RN
Am J Ophthalmol; 2004 May; 137(5):863-71. PubMed ID: 15126151
[TBL] [Abstract][Full Text] [Related]
10. Frequency-doubling perimetry: comparison with standard automated perimetry to detect glaucoma.
Leeprechanon N; Giangiacomo A; Fontana H; Hoffman D; Caprioli J
Am J Ophthalmol; 2007 Feb; 143(2):263-271. PubMed ID: 17178091
[TBL] [Abstract][Full Text] [Related]
11. Glaucomatous visual field progression with frequency-doubling technology and standard automated perimetry in a longitudinal prospective study.
Haymes SA; Hutchison DM; McCormick TA; Varma DK; Nicolela MT; LeBlanc RP; Chauhan BC
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):547-54. PubMed ID: 15671281
[TBL] [Abstract][Full Text] [Related]
12. Comparing multifocal VEP and standard automated perimetry in high-risk ocular hypertension and early glaucoma.
Fortune B; Demirel S; Zhang X; Hood DC; Patterson E; Jamil A; Mansberger SL; Cioffi GA; Johnson CA
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1173-80. PubMed ID: 17325161
[TBL] [Abstract][Full Text] [Related]
13. Humphrey matrix frequency doubling technology perimetry and optical coherence tomography measurement of the retinal nerve fiber layer thickness in both normal and ocular hypertensive subjects.
Mastropasqua L; Brusini P; Carpineto P; Ciancaglini M; Di Antonio L; Zeppieri MW; Parisi L
J Glaucoma; 2006 Aug; 15(4):328-35. PubMed ID: 16865011
[TBL] [Abstract][Full Text] [Related]
14. Humphrey matrix frequency doubling perimetry for detection of visual-field defects in open-angle glaucoma.
Clement CI; Goldberg I; Healey PR; Graham S
Br J Ophthalmol; 2009 May; 93(5):582-8. PubMed ID: 18669543
[TBL] [Abstract][Full Text] [Related]
15. Testing for glaucoma with frequency-doubling perimetry in normals, ocular hypertensives, and glaucoma patients.
Horn FK; Wakili N; Jünemann AM; Korth M
Graefes Arch Clin Exp Ophthalmol; 2002 Aug; 240(8):658-65. PubMed ID: 12192460
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity and specificity of frequency doubling perimetry in neuro-ophthalmic disorders: a comparison with conventional automated perimetry.
Wall M; Neahring RK; Woodward KR
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1277-83. PubMed ID: 11923276
[TBL] [Abstract][Full Text] [Related]
17. Corneal thickness measurements and frequency doubling technology perimetry abnormalities in ocular hypertensive eyes.
Medeiros FA; Sample PA; Weinreb RN
Ophthalmology; 2003 Oct; 110(10):1903-8. PubMed ID: 14522761
[TBL] [Abstract][Full Text] [Related]
18. Glaucoma detection with frequency doubling perimetry and short-wavelength perimetry.
Horn FK; Brenning A; Jünemann AG; Lausen B
J Glaucoma; 2007; 16(4):363-71. PubMed ID: 17570999
[TBL] [Abstract][Full Text] [Related]
19. Repeatability of frequency doubling technology perimetry (20-1 screening program) and the effect of pupillary dilatation on interpretation.
Parikh R; Muliyil J; George R; Bhat S; Thomas R
Ophthalmic Epidemiol; 2008; 15(1):42-6. PubMed ID: 18300088
[TBL] [Abstract][Full Text] [Related]
20. Impact of diabetes on glaucoma screening using frequency-doubling perimetry.
Realini T; Lai MQ; Barber L
Ophthalmology; 2004 Nov; 111(11):2133-6. PubMed ID: 15522382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
